NIPPON MEDICAL SCHOOL FOUNDATION has a total of 35 patent applications. Its first patent ever was published in 2003. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets biotechnology, medical technology and pharmaceuticals are KING FAISAL SPECIALIST HOSPITA, KING FAISAL SPECIALIST HOSPITAL & RES CENTRE and AMC AMSTERDAM.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 9 | |
#2 | EPO (European Patent Office) | 7 | |
#3 | United States | 5 | |
#4 | China | 4 | |
#5 | Japan | 3 | |
#6 | Republic of Korea | 2 | |
#7 | Australia | 1 | |
#8 | Canada | 1 | |
#9 | Malaysia | 1 | |
#10 | Russian Federation | 1 | |
#11 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Medical technology | |
#3 | Pharmaceuticals | |
#4 | Measurement | |
#5 | Foods and drinks | |
#6 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Diagnosis and surgery | |
#2 | Peptides | |
#3 | Microorganisms | |
#4 | Medical preparations | |
#5 | Therapeutic chemical compounds | |
#6 | Electrotherapy | |
#7 | Analysing materials | |
#8 | Water treatment | |
#9 | Object sterilising | |
#10 | Foods |
# | Name | Total Patents |
---|---|---|
#1 | Inoue Toshiki | 11 |
#2 | Okada Takashi | 11 |
#3 | Matsumoto Satoshi | 10 |
#4 | Nakamura Yoshiharu | 10 |
#5 | Mineno Junichi | 7 |
#6 | Okada Hironori | 6 |
#7 | Suzuki Hidenori | 5 |
#8 | Sakai Atsushi | 5 |
#9 | Kinoh Hiromi | 5 |
#10 | Enoki Tatsuji | 5 |
Publication | Filing date | Title |
---|---|---|
WO2021002412A1 | Method for producing nucleic acid-encapsulated aav hollow particle | |
WO2020067485A1 | Inducer of cardiac ability to synthesize acetylcholine | |
WO2019176901A1 | Relief from osteoarthritis pain by targeting microrna-21 | |
EP3751000A1 | Improved adeno-associated virus vector | |
US2020289856A1 | Ultrasonic treatment apparatus | |
CN110462037A | The mutant of adeno-associated virus (AAV) capsid protein | |
WO2018139637A1 | Nucleic acid-encapsulating aav empty particles | |
WO2012077828A1 | Therapeutic agent for inflammatory diseases, which can inhibit function of inflammatory cytokine | |
WO2010150874A1 | Inter-organ spacer for surgery | |
EP2233101A1 | Organ spacer for scope-assisted surgery | |
EP2050467A1 | Therapeutic agent for amyotrophic lateral sclerosis |